Literature DB >> 17029337

Endovascular treatment strategies for cerebral vasospasm.

Stefan A Mindea1, Benson P Yang, Bernard R Bendok, Jeffrey W Miller, H Hunt Batjer.   

Abstract

Cerebral vasospasm is a significant cause of morbidity and mortality in patients who have sustained a subarachnoid hemorrhage from aneurysm rupture. Symptomatic cerebral vasospasm is also a strong predictor of poor clinical outcome and has thus drawn a great deal of interest from cerebrovascular surgeons. Although medical management is the cornerstone of treatment for this condition, endovascular intervention may be warranted for those in whom this treatment fails and in whom symptomatic vasospasm subsequently develops. The rapid advancements in endovascular techniques and pharmacological agents used to combat this pathological state continue to offer promise in broadening the available treatment armamentarium. In this article the authors discuss the rationale and basis for using the various endovascular options for the treatment of cerebral vasospasm, and they also discuss the limitations, complications, and efficacy of these treatment strategies in regard to neurological condition and outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029337     DOI: 10.3171/foc.2006.21.3.13

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  9 in total

Review 1.  Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature.

Authors:  Christos Lazaridis; Gustavo Pradilla; Paul A Nyquist; Rafael J Tamargo
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

2.  Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage.

Authors:  Jai Jai Shiva Shankar; Marlise P dos Santos; Leonardo Deus-Silva; Cheemun Lum
Journal:  Neuroradiology       Date:  2010-06-05       Impact factor: 2.804

Review 3.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

4.  Intraarterial nimodipine infusion to treat symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jong Hoon Kim; In Sung Park; Kyung Bum Park; Dong-Ho Kang; Soo Hyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2009-09-30

5.  Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note.

Authors:  Johannes Platz; Krisztina Baráth; Emanuela Keller; Anton Valavanis
Journal:  Neuroradiology       Date:  2008-09-13       Impact factor: 2.804

6.  Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury.

Authors:  Thekla Cordes; Alfredo Lucas; Ajit S Divakaruni; Anne N Murphy; Pedro Cabrales; Christian M Metallo
Journal:  Mol Metab       Date:  2019-12-13       Impact factor: 7.422

Review 7.  Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.

Authors:  Salah G Keyrouz; Michael N Diringer
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  Papaverine Prevents Vasospasm by Regulation of Myosin Light Chain Phosphorylation and Actin Polymerization in Human Saphenous Vein.

Authors:  Kyle M Hocking; Gowthami Putumbaka; Eric S Wise; Joyce Cheung-Flynn; Colleen M Brophy; Padmini Komalavilas
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

9.  Endovascular Treatment of Symptomatic Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Three-year Experience.

Authors:  Eun-Sung Park; Dae-Won Kim; Sung-Don Kang
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2017-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.